Study Evaluating Venetoclax in Subjects With Hematological Malignancies
Status:
Completed
Trial end date:
2021-03-12
Target enrollment:
Participant gender:
Summary
This study is evaluating the safety, pharmacokinetic profile and efficacy of venetoclax under
a once daily dosing schedule in Japanese participants with hematological malignancies.